Back to search
FDAFDA · Food and drugs·Recall number Z-1707-2026

THORACIC ROBOTS, DYNJ908777B

Published April 8, 2026 · Recall initiated: February 16, 2026

Summary

FDA records medical device Class II recall Z-1707-2026, published April 8, 2026 and initiated February 16, 2026. Recalling firm: Medline Industries, LP; Status: Ongoing; Reported quantity: 14,379 kits total; Lot: UDI-DI 10198459269196 (EA) 40198459269197 (CS) LOTS 25EBD732 25GBG733 25IBQ613 25JBD457 25KBT352 26ABA235 26ABP735. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Kits contain recalled Olympus biopsy valves. Olympus is investigating an increase in complaints associated with rubber fragment detachment in the slit of single use biopsy valves. Potential consequences associated with detachment of fragments from valve include foreign body in patient's tracheobronchial tree, which may require intervention for removal. Other potential consequences include inflammatory response, hypoxia, and prolongation of procedure.

What to do

Voluntary: Firm initiated

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Medline Industries, LP
Distributor
US Nationwide distribution in the states of CA, FL, IL, IN, KY, MA, MD, MT, NY, OH, PA, TN, TX.
Lot
UDI-DI 10198459269196 (EA) 40198459269197 (CS) LOTS 25EBD732 25GBG733 25IBQ613 25JBD457 25KBT352 26ABA235 26ABP735
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was THORACIC ROBOTS, DYNJ908777B recalled?

Yes. FDA published recall Z-1707-2026 on April 8, 2026. Reported hazard: Kits contain recalled Olympus biopsy valves. Olympus is investigating an increase in complaints associated with rubber fragment detachment in the slit of single use biopsy valves. Potential consequences associated with detachment of fragments from valve include foreign body in patient's tracheobronchial tree, which may require intervention for removal. Other potential consequences include inflammatory response, hypoxia, and prolongation of procedure.

What should I do if I have this product?

Voluntary: Firm initiated